The agency is going to hold a public workshop on Dec. 6 & 7 in conjunction with the NIH and the Consumer Healthcare Products Association. The idea, according to the FDA, is to gain a “better understanding” of how OTC drugs are used by adolescents - kids between 12 and 18 years old. The agency also hopes to figure out how teenage decision-making contrasts with adult decision-making when it comes to using OTC meds.

This comes on the heels of an FDA panel meeting that decided children younger than 6 years old shouldn’t be getting OTC cough and cold meds. The info from the upcoming workshop will be used to determine when OTC drug studies should enroll adolescents and to define the type of research and study designs needed to support OTC drug product approval for adolescents, according to the FDA. You can read more in the Federal Register notice .